Squarepoint’s Array Biopharma Inc ARRY Stock Holding History

Squarepoint’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-11,232	Closed	-$520K	–	2875
2019 Q2	$520K	Sell	11,232 -35,426	-76%	-$995K	0.01%	1640
2019 Q1	$1.14M	Buy	46,658 +663	+1%	+$13.8K	0.01%	1037
2018 Q4	$655K	Buy	45,995 +11,593	+34%	+$176K	0.01%	1109
2018 Q3	$523K	Sell	34,402 -71,809	-68%	-$1.1M	0.01%	1281
2018 Q2	$1.78M	Sell	106,211 -915	-0.9%	-$14.6K	0.02%	677
2018 Q1	$1.75M	Buy	+107,126	New	+$1.72M	0.03%	618
2017 Q4	–	Sell	-29,092	Closed	-$358K	–	2461
2017 Q3	$358K	Buy	+29,092	New	+$270K	0.01%	1102
2017 Q2	–	Sell	-30,100	Closed	-$269K	–	1962
2017 Q1	$269K	Sell	30,100 -27,900	-48%	-$297K	0.01%	1141
2016 Q4	$510K	Buy	+58,000	New	+$427K	0.02%	818
2016 Q3	–	Sell	-58,100	Closed	-$207K	–	1387
2016 Q2	$207K	Buy	+58,100	New	+$189K	0.01%	884
2016 Q1	–	Sell	-92,500	Closed	-$390K	–	1581
2015 Q4	$390K	Buy	+92,500	New	+$422K	0.04%	669

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Squarepoint's ARRY Position: Q3 2019 in Review

Squarepoint sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 11,232 shares — an estimated $520K sold.

Squarepoint first reported a position in ARRY in Q4 2015 and held it in 11 quarters. The position peaked at $1.78M in Q2 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Squarepoint reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Squarepoint sold 11,232 Array Biopharma Inc shares in Q3 2019, an estimated $520K.
Squarepoint first reported a position in Array Biopharma Inc in Q4 2015 and held it in 11 quarters.
Squarepoint's Array Biopharma Inc position peaked at $1.78M in Q2 2018.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Squarepoint's 13F filing for Q3 2019, filed 14 Nov 2019.